Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study. (Q43254495)
Jump to navigation
Jump to search
scientific article published on 26 October 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study. |
scientific article published on 26 October 2009 |
Statements
Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study (English)
Richard S Finn
Robert Gagnon
Michael F Press
Michael Arbushites
Maria Koehler
26 October 2009